-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Astria Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- Astria Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$24.2M, a 92.4% decline year-over-year.
- Astria Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$93.2M, a 90.2% decline year-over-year.
- Astria Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$72.9M, a 40.6% decline from 2022.
- Astria Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$51.8M, a 73.4% increase from 2021.
- Astria Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$195M, a 423% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)